The Progressive Supranuclear Palsy Clinical Trial Platform (PTP) is a multi-center, multi-regimen clinical trial evaluating the safety and efficacy of investigational products for the treatment of PSP. Regimen B will evaluate the safety and efficacy of a single study drug, LM11A-31, in participants with PSP.
Phase:
PHASE2
Details
Lead Sponsor:
Adam Boxer
Collaborators:
Alzheimer's Clinical Trials Consortium Alzheimer's Therapeutic Research Institute Massachusetts General Hospital National Institute on Aging (NIA) PharmatrophiX Inc. University of California, San Diego University of Southern California